Literature DB >> 11046204

Minimum alveolar concentration-awake of Xenon alone and in combination with isoflurane or sevoflurane.

T Goto1, Y Nakata, Y Ishiguro, Y Niimi, K Suwa, S Morita.   

Abstract

BACKGROUND: The minimum alveolar concentration (MAC)-awake is a traditional index of hypnotic potency of an inhalational anesthetic. The MAC-awake of xenon, an inert gas with anesthetic properties (MAC = 71%), has not been determined. It is also unknown how xenon interacts with isoflurane or sevoflurane on the MAC-awake.
METHODS: In the first part of the study, 90 female patients received xenon, nitrous oxide (N2O), isoflurane, or sevoflurane supplemented with epidural anesthesia (n = 36 for xenon and n = 18 per group for other anesthetics). In the second part, 72 additional patients received either xenon or N2O combined with the 0.5 times MAC-awake concentration of isoflurane or sevoflurane (0.2% and 0.3%, respectively, based on the results of the first part; n = 18 per group). During emergence, the concentration of an assigned anesthetic (xenon or N2O only in the second part) was decreased in 0. 1 MAC decrements every 15 min from 0.8 MAC or from 70% in the case of N2O until the patient followed the command to either open her eyes or to squeeze and release the investigator's hand. The concentration midway between the value permitting the first response to command and that just preventing it was defined as the MAC-awake.
RESULTS: The MAC-awake were as follows: xenon, 32.6 +/- 6.1% (mean +/- SD) or 0.46 +/- 0.09 MAC; N2O, 63.3 +/- 7.1% (0.61 +/- 0.07 MAC); isoflurane, 0.40 +/- 0.07% (0.35 +/- 0.06 MAC); and sevoflurane, 0.59 +/- 0.10% (0.35 +/- 0.06 MAC). Addition of the 0.5 MAC-awake concentrations of isoflurane and sevoflurane reduced the MAC-awake of xenon to 0.50 +/- 0.15 and 0.51 +/- 0.16 times its MAC-awake as a sole agent, but that of N2O to the values significantly greater than 0.5 times its MAC-awake as a sole agent (0.68 +/- 0.12 and 0.66 +/- 0.14 times MAC-awake; P < 0.01, analysis of variance and Dunnett's test).
CONCLUSIONS: The MAC-awake of xenon is 33% or 0.46 times its MAC. In terms of the MAC-fraction, this is smaller than that for N2O but greater than those for isoflurane and sevoflurane. Unlike N2O, xenon interacts additively with isoflurane and sevoflurane on MAC-awake.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11046204     DOI: 10.1097/00000542-200011000-00009

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

Review 1.  General anesthetics and molecular mechanisms of unconsciousness.

Authors:  Stuart A Forman; Victor A Chin
Journal:  Int Anesthesiol Clin       Date:  2008

2.  Effect of flumazenil on sevoflurane requirements for minimum alveolar anesthetic concentration-awake and recovery status.

Authors:  Peng Liang; Cheng Zhou; Kai-Yu Li; Li-Juan Guo; Bin Liu; Jin Liu
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 3.  Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection.

Authors:  Robert Dickinson; Nicholas P Franks
Journal:  Crit Care       Date:  2010-08-12       Impact factor: 9.097

4.  Monitoring xenon in the breathing circuit with a thermal conductivity sensor. Comparison with a mass spectrometer and implications on monitoring other gases.

Authors:  Martin Luginbühl; Rolf Lauber; Peter Feigenwinter; Alex M Zbinden
Journal:  J Clin Monit Comput       Date:  2002-01       Impact factor: 2.502

5.  Response surface model predictions of emergence and response to pain in the recovery room: An evaluation of patients emerging from an isoflurane and fentanyl anesthetic.

Authors:  Noah D Syroid; Ken B Johnson; Nathan L Pace; Dwayne R Westenskow; Diane Tyler; Frederike Brühschwein; Robert W Albert; Shelly Roalstad; Samuel Costy-Bennett; Talmage D Egan
Journal:  Anesth Analg       Date:  2010-08       Impact factor: 5.108

6.  Xenon Anesthesia and CT: Noninvasive Measures of Brain Anesthetic Concentration.

Authors:  Andrew McKinstry-Wu; Charles W Carspecken; Alex Proekt; Max B Kelz
Journal:  Methods Enzymol       Date:  2018-03-03       Impact factor: 1.600

7.  Safety and feasibility of xenon as an adjuvant to sevoflurane anaesthesia in children undergoing interventional or diagnostic cardiac catheterization: study protocol for a randomised controlled trial.

Authors:  Sarah Devroe; Jurgen Lemiere; Marc Van de Velde; Marc Gewillig; Derize Boshoff; Steffen Rex
Journal:  Trials       Date:  2015-03-04       Impact factor: 2.279

8.  The breast feeding mother and xenon anaesthesia: four case reports. Breast feeding and xenon anaesthesia.

Authors:  Ralph Stuttmann; Claudia Schäfer; Peter Hilbert; Markus R Meyer; Hans H Maurer
Journal:  BMC Anesthesiol       Date:  2010-02-19       Impact factor: 2.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.